ISTH 2020 Congress

C. Bravo-Perez¹, M. Toderici¹, B. de la Morena-Barrio¹, J. Padilla¹, A. Miñano¹, A. Palomo², H. Perez-Sanchez³, J. Martinez-Menarguez⁴, J. Chambers⁵, S. Marciniak⁵, V. Vicente¹, J. Corral¹, M.E. de la Morena-Barrio¹

Abstract Number: PB0310

Bleeding and Thrombotic Complications in Patients Undergoing Major Cardiac Surgery on Single, Dual Antiplatelet Treatment Compared to Controls

C. Little¹, T. Aw², R. Szydlo³, M. Laffan¹, D. Arachchillage^1,4

Abstract Number: PB0322

Bleeds and Imaging Scores in Relation to Pharmacokinetics of Coagulation Factor VIII in Chinese Pediatric Patients with Severe Hemophilia A

H. Kun, Z. Chen, G. Li, R. Wu, Y. Zhen, N. Zhang

Abstract Number: PB0137

Cardiac Myosin Promotes Thrombin Generation and Coagulation in vitro and in vivo

M. Shukla¹, H. Deguchi¹, J. Zilberman-Rudenko^1,2, Y. Oyama³, T. Eckle³, Z. Guo¹, S. Lear¹, W. Shen¹, T. Wyseure¹, L. Mosnier¹, J. Orje¹, Z. Ruggeri¹, O. McCarty², J. Griffin¹

Abstract Number: PB0206

Characterisation and Evaluation of a Candidate Bethesda Assay Reference Reagent Developed from Recombinant, Patient-Derived FVIII Inhibitors

C. Coxon¹, J. Beavis², X. Yu³, S. Diamond³, A. Riches¹, S. Raut¹

Abstract Number: PB0376

Characterisation of Plasma Microvesicles in Type 2 Diabetes mellitus Patients with and without Microalbuminuria

A. Vaidya¹, K. Gooding¹, A. Shore¹, G. Pula^1,2

Abstract Number: PB0209

Circulating T Helper 17 Cells (Th17) Increase at a Higher Rate than Tregs in Previously Untreated Patients with Severe Hemophilia A Who Develop Inhibitors During the First 50 Exposure Days to rFVIII

D. Brown¹, V. Berg², J. Blatny³, K. Fijnvandraat⁴, J. Klintman⁵, C. Male⁶, C. McGuinn⁷, S. Meeks⁸, E. Mullins⁹, V. Radelescu¹⁰, M. Ragni¹¹, M. Recht¹², E. Santagostino¹³, A. Shapiro¹⁴, J. Staber¹⁵, H. Yaish¹⁶, P. LeBeau¹⁷, J. Bowen¹⁷, B. Gangadharan¹⁸, B. Reipert¹⁸

Abstract Number: PB0288

Clinical Outcome of Using Three-Factor Prothrombin Complex Concentrate in Patients with Major Bleeding Associated with Factor Xa Inhibitor

T. Raksintham¹, Y. Chinthammitr², T. Ruchutrakool³, B. Suwannawiboon³

Abstract Number: PB0388

ISTH 2020 Congress

Coagulation and Natural Anticoagulants

Are the Plasma Levels Thresholds of DOAC Rationale and Appropriate for Clinical Decision-making? A Reappraisal Using Thrombin Generation Testing

Are Therapeutic Immunoglobulins Free from Factor XIa?

Assessment of Coagulation Factor Levels in LVAD Patients Following Temporary Warfarin Reversal with 4F-PCC (KVAD Study)

Assessment of Four Factor Prothrombin Complex Concentrate (4F-PCC) Usage in Emergency Department Patients: A Single Center Experience

Assessment of the Difference Between EXTEM and FIBTEM Amplitudes (PLTEM) and Their Correlation with Platelet Count (PLT), and the Effect of Fibrinogen and Hematocrit (HTC) in Cardiovascular Surgery (CVS)

B Cell Cytokines in Italian Hemophilia A Patients with Inhibitors

Baseline VWF Antigen Level Is Associated with the Outcome of Immune Tolerance Induction Using pdFVIII/VWF Concentrate in Hemophilia A with Inhibitor

Bisecting the Role of the C-terminal End of Antithrombin: Natural Variants due to a Frameshift at Different Secondary Structures May Exacerbate or Ameliorate a New Dominant-negative Effect

Bleeding and Thrombotic Complications in Patients Undergoing Major Cardiac Surgery on Single, Dual Antiplatelet Treatment Compared to Controls

Bleeds and Imaging Scores in Relation to Pharmacokinetics of Coagulation Factor VIII in Chinese Pediatric Patients with Severe Hemophilia A

Cardiac Myosin Promotes Thrombin Generation and Coagulation in vitro and in vivo

Characterisation and Evaluation of a Candidate Bethesda Assay Reference Reagent Developed from Recombinant, Patient-Derived FVIII Inhibitors

Characterisation of Plasma Microvesicles in Type 2 Diabetes mellitus Patients with and without Microalbuminuria

Circulating T Helper 17 Cells (Th17) Increase at a Higher Rate than Tregs in Previously Untreated Patients with Severe Hemophilia A Who Develop Inhibitors During the First 50 Exposure Days to rFVIII

Clinical Outcome of Using Three-Factor Prothrombin Complex Concentrate in Patients with Major Bleeding Associated with Factor Xa Inhibitor

Clinical Presentation and Management of Homozygous Protein C Deficiency: Cukurova Experience

Clinical Significance of T-cell Subsets for the Inhibitor Development in Pediatric Hemophilia A Patients

Clinical Study of Children’s Intracranial Hemorrhage in Single Hemophilia Center in China

Coagulation Assays Based on Surface-Mimicking Antibodies against Factor XII

Coagulation Factor IIIa (f3a) Knockdown in Zebrafish Leads to Defective Angiogenesis and Bleeding Phenotype